Fragment-Based Methods in Drug Discovery /

Detalles Bibliográficos
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Klon, Anthony E. (Editor )
Formato: eBook
Lenguaje:English
Publicado: New York, NY : Springer New York : Imprint: Humana, 2015.
Edición:1st ed. 2015.
Colección:Methods in Molecular Biology, 1289
Materias:
LEADER 02115nam a22002775i 4500
001 000283346
005 20210729094608.0
007 cr nn 008mamaa
008 150223s2015 xxu| s |||| 0|eng d
020 |a 9781493924868 
024 7 |a 10.1007/978-1-4939-2486-8  |2 doi 
040 |a Sistema de Bibliotecas del Tecnológico de Costa Rica 
245 1 0 |a Fragment-Based Methods in Drug Discovery /  |c edited by Anthony E. Klon. 
250 |a 1st ed. 2015. 
260 # # |a New York, NY :  |b Springer New York :  |b Imprint: Humana,  |c 2015. 
300 |a IX, 230 p. 68 illus., 53 illus. in color. :  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Methods in Molecular Biology,  |v 1289 
505 0 |a Solvation Methods for Protein-Ligand Docking -- Binding Site Druggability Assessment in Fragment-Based Drug Design -- Generating "Fragment-Based Virtual Library" Using Pocket Similarity Search of Ligand-Receptor Complexes -- Virtual Fragment Preparation for Computational Fragment-Based Drug Design -- Fragment Library Design: Using Cheminformatics and Expert Chemists to Fill Gaps in Existing Fragment Libraries -- Protocol for Fragment Hopping -- Site Identification by Ligand Competitive Saturation (SILCS) Simulations for Fragment-Based Drug Design -- A Computational Fragment-Based De Novo Design Protocol Guided by Ligand Efficiency Indices (LEI) -- Scoring Functions for Fragment-Based Drug Discovery -- Computational Methods for Fragment-Based Ligand Design: Growing and Linking -- Design Strategies for Computational Fragment-Based Drug Design -- Protein Binding Site Analysis for Drug Discovery Using a Computational Fragment-Based Method -- Fragment-Based Design of Kinase Inhibitors: A Practical Guide -- Designing a Small Molecule Erythropoietin Mimetic -- Designing an Orally Available Non-Toxic p38 Inhibitor with a Fragment-Based Strategy. 
650 0 |a Pharmacology. 
650 1 4 |a Pharmacology/Toxicology. 
700 1 |a Klon, Anthony E.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks